Doctors now have powerful new medications to help people lose weight. These drugs work by making your brain feel fuller faster, so you eat less. Three main medications—liraglutide, semaglutide, and tirzepatide—have shown impressive results in studies, helping people lose between 17 and 22 pounds over several months. What’s exciting is that these medications work almost as well as weight loss surgery, but without needing an operation. This gives people more options for treating obesity as a serious health condition, similar to how we treat diabetes or high blood pressure.
The Quick Take
- What they studied: How well new weight loss medications work compared to other obesity treatments like surgery and lifestyle changes
- Who participated: This was a review of research studies on obesity treatments; no single group of participants was studied
- Key finding: Three new medications (liraglutide, semaglutide, and tirzepatide) help people lose significant amounts of weight—up to 22.5 pounds in some cases—by making them feel fuller longer
- What it means for you: If you struggle with weight loss through diet and exercise alone, these medications may be an option worth discussing with your doctor. They’re not a magic solution but can help when combined with healthy eating and activity
The Research Details
This article reviews the current state of obesity treatment, focusing on new medications called GLP-1 and GLP-1/GIP receptor agonists. These drugs work by activating special receptors in your brain and stomach that tell your body you’re full, reducing hunger and helping you eat less. The review summarizes results from multiple clinical trials testing these medications in real patients over weeks and months.
The researchers looked at three main medications: liraglutide (which showed average weight loss of 16.5 pounds over about 3 years), semaglutide (which showed up to 38 pounds lost over about 1.5 years), and tirzepatide (which showed up to 49.5 pounds lost over about 1.5 years). They also examined how these results compared to weight loss surgery and traditional lifestyle approaches.
The review emphasizes that obesity is now recognized as a chronic disease—a long-term health condition like diabetes—rather than just a personal problem. This changes how doctors approach treatment, using a step-by-step plan starting with diet, exercise, and behavior change, then adding medications if needed, and finally considering surgery for appropriate candidates.
Understanding how these new medications work is important because obesity affects millions of people and increases the risk of heart disease, diabetes, and other serious health problems. For many people, diet and exercise alone aren’t enough. Having effective medication options that work almost as well as surgery but without surgery’s risks and costs gives people real alternatives and hope for managing their weight and improving their health.
This is a review article summarizing existing research rather than a new study with participants. The information comes from clinical trials that tested these medications in real patients. The medications discussed are approved for use in Germany and have been studied extensively. However, the article doesn’t provide details about how many people were studied overall or the specific quality of each individual study. The findings are based on established clinical trials, which is a strength, but readers should know this is a summary of other research rather than original new data.
What the Results Show
The three new medications show impressive weight loss results. Liraglutide helped people lose an average of 16.5 pounds over three years. Semaglutide was more powerful, with people losing up to 38 pounds in about 68 weeks (roughly 1.5 years). Tirzepatide was the strongest, with people losing up to 49.5 pounds in about 72 weeks (also roughly 1.5 years).
What makes these results especially important is that they’re close to what people achieve with weight loss surgery, but without needing an operation. This is significant because surgery carries risks and isn’t available or appropriate for everyone. These medications work by activating special receptors in your brain and digestive system that increase feelings of fullness, naturally reducing how much you eat.
Beyond just weight loss, semaglutide also showed positive effects on heart health in clinical trials. This means it may help prevent heart disease and other cardiovascular problems, not just help people lose weight. The medications are currently available in Germany, though they may require patients to pay out-of-pocket since they’re not yet covered by all insurance plans.
An important secondary finding is that these medications work best when combined with lifestyle changes—healthy eating, exercise, and behavior modification—rather than as a standalone treatment. The research suggests these drugs should be used as an additional tool when people can’t achieve their weight loss goals through lifestyle changes alone. The fact that semaglutide showed cardiovascular benefits is particularly noteworthy, suggesting these medications may do more than just help with weight loss; they may actually improve overall heart health.
This research represents a major advancement in obesity treatment. Previously, the most effective option for significant weight loss was bariatric surgery (weight loss surgery), which involves changing the stomach or intestines. These new medications now achieve weight loss results that are comparable to surgery, which is a breakthrough. Before these drugs, people had limited options: lifestyle changes alone (which work for some but not all), older weight loss medications (which were less effective), or surgery (which carries surgical risks). These new medications fill an important gap in the middle, offering a powerful option that doesn’t require surgery.
This article is a review of existing research rather than a new study, so it doesn’t provide completely new data. The article doesn’t specify exactly how many people participated in all the studies combined. The medications discussed are relatively new, so long-term effects beyond a few years aren’t yet known. The article focuses on results from clinical trials, which may not perfectly reflect how well these medications work in everyday life for all patients. Additionally, these medications are expensive and not yet covered by all insurance plans, which limits access for many people. The article also doesn’t deeply discuss potential side effects or who shouldn’t use these medications.
The Bottom Line
If you’re struggling with weight loss despite trying diet and exercise, talk to your doctor about whether one of these medications might help. Start with lifestyle changes (healthy eating, regular activity, and behavior modification), and consider medication as an additional tool if those alone aren’t working. These medications appear most effective when combined with ongoing healthy habits. Confidence level: Moderate to High—these medications have been tested in clinical trials and show real results, but they work best as part of a complete approach to health.
This research is most relevant for adults who have obesity or significant weight to lose and haven’t succeeded with diet and exercise alone. It’s also important for people with weight-related health problems like diabetes or heart disease. Healthcare providers should pay attention to these options when helping patients with obesity. People who are pregnant, breastfeeding, or have certain medical conditions should discuss with their doctor whether these medications are appropriate. This research is less relevant for people who can achieve their weight goals through lifestyle changes alone.
Weight loss with these medications typically begins within weeks, with noticeable results usually appearing within 2-3 months. The studies showed significant weight loss over 1-3 years, so these are not quick-fix medications. You should expect to stay on the medication long-term (similar to taking blood pressure or diabetes medication) to maintain the weight loss. Benefits may continue to improve over the first year of treatment.
Want to Apply This Research?
- If using one of these medications, track your weekly weight and how full you feel after meals on a scale of 1-10. Also note any side effects and your energy levels. This helps you and your doctor see if the medication is working well for you and if any adjustments are needed.
- Use the app to log your meals and track portion sizes. Since these medications help you feel fuller, the app can help you notice and celebrate eating smaller portions naturally. Set reminders for regular physical activity and track exercise minutes. Use the app to record your hunger levels throughout the day to see how the medication affects your appetite over time.
- Create a monthly check-in routine in the app where you record your weight, how you’re feeling overall, any side effects, and whether you’re meeting your activity goals. Set a reminder to discuss your progress with your doctor every 3 months. Track trends over 3-6 month periods rather than daily fluctuations, since weight loss with these medications is gradual. Use the app to identify patterns—like whether you lose weight faster when you exercise more or eat certain foods.
This article reviews medical research about obesity treatments and new weight loss medications. It is for educational purposes only and should not replace professional medical advice. These medications are prescription drugs that require a doctor’s evaluation and monitoring. They may not be appropriate for everyone and can have side effects. If you’re considering these medications, consult with your healthcare provider to discuss whether they’re right for you, potential risks and benefits, and how they fit into your overall health plan. Pregnant women, people with certain medical conditions, and those taking specific medications should not use these drugs without medical supervision. This information reflects current research but medical knowledge evolves, so discuss the latest evidence with your doctor.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
